FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to the new chemical compound - 3-benzylaminomethylenepyrrolidine-2,4-dione. Compound shows the more expressed anticonvulsant activity, broad spectrum of action and decreased toxicity as compared with the known anticonvulsant preparation widely used in clinics. Invention describes also the drug eliciting anticonvulsant effect. EFFECT: new compound indicated above, improved properties of compound. 3 cl, 12 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 4-BENZOYLPYRIDINE OXIME DERIVATIVES HAVING ANTICONVULSANT ACTIVITY AS AGENTS FOR TREATMENT OF EPILEPSY AND PAROXYSMAL STATES | 2016 |
|
RU2643091C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PAROXYSMAL CONDITIONS | 2011 |
|
RU2469722C1 |
| DIBENZOFURAN OXIME DERIVANTS WITH ANTICONVULSANT AND NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2744758C2 |
| METHOD OF DETECTING ANTICONVULSANT ACTION OF SODIUM CITICOLINE AND VALPROATE WHEN APPLYING THEM TOGETHER ON MODEL OF ACUTE GENERALIZED CONVULSIONS CAUSED BY PENTYLENETETRAZOLE IN WISTAR MALE RATS | 2015 |
|
RU2600477C1 |
| ANTISTRESS, STRESS-PROTECTIVE, NOOTROPIC AGENT, METHOD OF PROPHYLAXIS AND TREATMENT OF STRESS STATES AND A METHOD OF MENTAL WORKIN CAPACITY INCREASE | 1992 |
|
RU2025124C1 |
| DERIVATIVE PYRIDOXIN FOR TREATMENT OF EPILEPSY | 2017 |
|
RU2650523C1 |
| THERAPEUTIC PREPARATION AT SPASMODIC SYNDROME | 2001 |
|
RU2191017C1 |
| 4-(3,4-DIBROMOTHIOPHENE CARBONYL)-2,6,8,12-TETRAACETYL-2,4,6,8,10,12-HEXAAZATETRACYCLO[5,5,0,0,0]DODECANE USED AS AN ANTICONVULSANT | 2018 |
|
RU2684107C1 |
| NEUROTROPIC DRUG AND METHOD FOR ITS PRODUCTION | 2007 |
|
RU2359962C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTICONVULSANT ACTIVITY FOR PARENTERAL INTRODUCTION | 2011 |
|
RU2463052C1 |
